EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Metabolic permissiveness: how tissue context shapes cancer

Chrysanthi Moschandrea iD, Christian Frezza iD

Genes & Development · 2026

DOI: 10.1101/gad.353516.125 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes & Development, 2026. Verfasst von Chrysanthi Moschandrea und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and University Hospital Cologne, Institute for Metabolomics in Ageing, Cluster of Excellence Cellular Stress Responses in Aging-A…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: “Stamatis G. Mantzavinos” Postdoctoral Scholarship, Bodossaki Foundation, Köln Fortune Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An emerging paradox in cancer metabolism is that identical oncogenic mutations produce profoundly different metabolic phenotypes depending on tissue context, with many mutations exhibiting striking tissue-restricted distributions. Here we introduce metabolic permissiveness as the inherent capacity of a tissue to tolerate, adapt to, or exploit metabolic disruptions, providing a unifying framework for explaining this selectivity. We examine tissue-specific metabolic rewiring driven by canonical oncogenes (MYC and KRAS), tumor suppressors (p53, PTEN, and LKB1), and tricarboxylic acid (TCA) cycle enzymes (FH, SDH, and IDH), demonstrating that baseline metabolic architecture, nutrient microenvironment, redox buffering, and compensatory pathways determine whether mutations confer a selective advantage or metabolic crisis. We further discuss how the tumor microenvironment shapes metabolic adaptation and therapeutic vulnerability. This framework reveals shared principles of tissue-specific metabolic vulnerability in cancer and provides a mechanistic basis for precision metabolic therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansAnimalsMutationMetabolic ReprogrammingTumor MicroenvironmentCitric Acid CycleOncogenesOrgan Specificity

Stichwörter der Autor:innen

cancermetabolismpermissiveness

Autor:innen und Institutionen

  • Faculty of Medicine and University Hospital Cologne, Institute for Metabolomics in Ageing, Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germ…
  • Faculty of Mathematics and Natural Sciences, Institute of Genetics, Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.
  • Center for Molecular Medicine (CMMC), University of Cologne, 50931 Cologne, Germany.

ORCID-Profile: Chrysanthi Moschandrea, Christian Frezza

Förderung

  • “Stamatis G. Mantzavinos” Postdoctoral Scholarship
  • Bodossaki Foundation
  • Köln Fortune Program
  • Alexander von Humboldt Professorship
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Moschandrea, C., & Frezza, C. (2026). Metabolic permissiveness: how tissue context shapes cancer. Genes & Development. https://doi.org/10.1101/gad.353516.125

Vancouver

Moschandrea C, Frezza C. Metabolic permissiveness: how tissue context shapes cancer. Genes & Development. 2026. doi:10.1101/gad.353516.125

BibTeX
@article{Moschandrea2026,
  author = {Moschandrea, Chrysanthi and Frezza, Christian},
  title = {Metabolic permissiveness: how tissue context shapes cancer},
  journal = {Genes & Development},
  year = {2026},
  doi = {10.1101/gad.353516.125}
}
Kostenlos starten →